The Role of Incentives in Deciding to Receive the Available COVID-19 Vaccine in Israel

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

This study aimed to assess the Israeli public’s intention to get vaccinated immediately after the COVID-19 vaccine became available, and to determine the role of incentives beyond socio-demographic, health-related and behavioral factors, in predicting this intention. An online survey was conducted among adults in Israel (n = 461), immediately after the first COVID-19 vaccine became available (22 December 2020 to 10 January 2021). Two regressions were performed to investigate determinants of intention to receive the available COVID-19 vaccine and sense of urgency to receive the vaccine. Although many adults were willing to receive available COVID-19 vaccine, only 65% were willing to immediately receive the vaccine, 17% preferred to wait 3 months and 18% preferred to wait a year. The sense of urgency to get vaccinated differed by age, periphery level, perceived barriers, cues to action and availability. Incentives such as monetary rewards or the green pass did not increase the probability of getting vaccination immediately. Providing data on the role of incentives in increasing the intention to immediately receive the available COVID-19 vaccine is important for health policy makers and healthcare providers. Our findings underscore the importance of COVID-19 vaccine accessibility. Health policy makers should consider allocating funds for making the vaccine accessible and encourage methods of persuasion, instead of investing funds in monetary incentives.

Original languageEnglish
Article number77
JournalVaccines
Volume10
Issue number1
DOIs
StatePublished - 4 Jan 2022

Bibliographical note

Publisher Copyright:
© 2022 by the author. Licensee MDPI, Basel, Switzerland.

Keywords

  • Health belief model
  • Incentives
  • SARS-CoV-2
  • Vaccine acceptance

Fingerprint

Dive into the research topics of 'The Role of Incentives in Deciding to Receive the Available COVID-19 Vaccine in Israel'. Together they form a unique fingerprint.

Cite this